Doctors Rail Against Insurer’s New Anesthesia Time Limits

A recent policy change by health insurer Anthem Blue Cross Blue Shield (BCBS) has led to sharp criticism from the

Gerresheimer builds new production capacities for glass syringes at Skopje site

Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetics industries, is expanding

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your

Mercy and Anthem Blue Cross Blue Shield announced early Wednesday they reached a new contract agreement, which means more than

FARMINGTON HILLS, Mich., Dec. 4, 2024 /PRNewswire/ — LSPedia, a leading provider of traceability and compliance solutions for the pharmaceutical

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication

After IFPMA, GSCF, and IGBA submitted a joint opening statement at the fifth session of the Intergovernmental Negotiating Committee (INC-5) for

DEAR PEOPLE’S PHARMACY: If you watch television and see the drug commercials, diabetes is the happiest disease you could hope

Dr Adam Rodman, an expert in internal medicine at Beth Israel Deaconess Medical Center in Boston, confidently expected that chatbots

Fate Therapeutics’ current president of research and development, Bob Valamehr, will take over as president and CEO effective from 1